Drug Trial Radar · NCT07082816
Reformulated PG324 Ophthalmic Solution for Intraocular Pressure Reduction
Last checked: Nov 20, 2026Latest source record: Apr 21, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
489
Actual
Start
Sep 2, 2025
Primary completion
Apr 6, 2026
Study completion Apr 6, 2026
Sponsor
- Lead sponsor
- Alcon ResearchIndustry
- Sponsor type
- Industry
- First posted
- Jul 24, 2025
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is designed to see how safe and effective a new eye drop, called Reformulated PG324, is for lowering eye pressure in people with open-angle glaucoma (OAG) or ocular hypertension (OHT).
Conditions
- Ocular Hypertension
- Open Angle Glaucoma
Interventions
Netarsudil 0.01%/latanoprost 0.005% ophthalmic solutionDrug
Investigational ophthalmic solution
Netarsudil 0.02%/latanoprost 0.005% ophthalmic solutionDrug
Commercially available ophthalmic solution
Primary outcomes
What the sponsor says the trial is designed to measure.
- Mean Intraocular Pressure at each timepoint post-randomizationTime frame: Week 2, Week 6, Month 3 at 08:00, 10:00, 16:00 hours
Locations
30 sites in 1 country. Site status is shown where the registry gives one.
Trinity Research Group
Dothan, Alabama
Eye Doctors of Arizona
Phoenix, Arizona
Orange County Ophthalmology Medical Group
Garden Grove, California
United Medical Research Institute
Inglewood, California
Eye Research Foundation
Newport Beach, California
North Bay Eye Associates
Petaluma, California
Sacramento Eye Consultants
Sacramento, California
Central Florida Eye Specialists
DeLand, Florida
Glaucoma Specialists of South Florida
Delray Beach, Florida
East Coast Institute for Research, LLC
Jacksonville, Florida
Central Florida Eye Associates
Lakeland, Florida
The Eye Institute of West Florida
Largo, Florida
Lee Shettle Eye
Largo, Florida
North Georgia Eye Associates
Gainesville, Georgia
Coastal Research Associates
Roswell, Georgia
Kannarr Eye Care LLC
Pittsburg, Kansas
NorthEast Eye Research Associates, LLC
Westborough, Massachusetts
Coldwater Vision Research
Coldwater, Mississippi
Las Vegas Eye Institute
Henderson, Nevada
Rochester Ophthalmological Group
Rochester, New York
Albemarle Eye Center
Elizabeth City, North Carolina
Oculus Research, Inc.
Garner, North Carolina
CORE, Inc.
Shelby, North Carolina
Midwest Eye Center
Cincinnati, Ohio
University Hospitals Cleveland Medical Center
Cleveland, Ohio
Scott & Christie and Associates, PC
Cranberry Township, Pennsylvania
Southern College of Optometry
Memphis, Tennessee
Total Eye Care, PA
Memphis, Tennessee
The Eye Institute of Utah
Salt Lake City, Utah
Piedmont Eye Center
Lynchburg, Virginia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.